Ticker LaunchIPO · KRBP
Kiromic Biopharma, Inc.
Formerly Kiromic, Inc.
Kiromic Biopharma, Inc. (KRBP) priced its initial public offering on Oct 16, 2020 at $12.00 per share, raising $15M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $88M. ThinkEquity was lead-left underwriter, joined by Paulson. Sheppard Mullin advised the company and Venable advised the underwriters.
Kiromic Biopharma, Inc. is a target discovery and gene-editing company focused on immuno-oncology, using artificial intelligence and a proprietary neural network platform. Its target discovery engine, called Diamond, supports development of allogeneic CAR therapies for solid tumors.
- Status
- IPO
- Ticker
- KRBP
- Exchange
- Nasdaq Capital Market
- Priced
- Oct 16, 2020
- IPO price
- $12.00
- Raised
- $15M
- Market cap at IPO price
- $88M
- First filed
- May 11, 2020
- Underwriters
- ThinkEquity and Paulson
- Company counsel
- Sheppard Mullin
- Underwriters' counsel
- Venable
- Sector
- Biotech & pharma
- Country / state
- TX
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed May 11, 2020
- Latest amendment Oct 6, 2020
- Final prospectus (424B4) Oct 16, 2020
- All filings on EDGAR CIK 1792581
Other Biotech & pharma IPOs in 2020
- Opthea LtdOPT · Oct 19, 2020
- Aligos Therapeutics, Inc.ALGS · Oct 19, 2020 · $150M
- Praxis Precision Medicines, Inc.PRAX · Oct 16, 2020 · $190M
- Tarsus Pharmaceuticals, Inc.TARS · Oct 16, 2020 · $88M
- Codiak BioSciences, Inc.CDAK · Oct 14, 2020 · $82.5M
- Shattuck Labs, Inc.STTK · Oct 13, 2020 · $202M